Ayala Pharmaceuticals Inc (ADXS)

[mpreorder]

FBG - I was going to post this as a reply, but wanted everyone to see it. While your attitude may be understandable, and even a bit predictable considering your constant maligning of management, it is shortsighted. Many here, including myself, believe the true value of Advaxis' constructs will be in the combination realm. I recently reviewed the data on combination treatment on the mouse cervical cancer model with PD-1, and it is outstanding. You don't need to be a statistician or Ph.D., anyone can see the value just by looking at the graphs. I'm not sure, but I think it's also in the corporate presentation. So much the better if we get approval of Axal by itself first, but if it pans out as hoped we'll get another nice bump.
To rejuvenate your enthusiasm for Advaxis go take a look. And we don't have to wait much longer either - I believe the first look at combo results are due this half. (Someone please correct me if I'm wrong.) If these results are similar to the mouse model they'll be nothing stopping us.
I'm still adding when I can and am hoping to still get leverage out of the warrants, but may have to plan an exit from those if nothing materializes by the fall.
Your patience is wearing thin; I think you've been here longer than me and I've been here since 2010 and I still think Advaxis will not only give me a much better retirement, but give me something that Neal Stephenson refers to as F*** YOU! money!!